1. Home
  2. GOLF vs RYTM Comparison

GOLF vs RYTM Comparison

Compare GOLF & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acushnet Holdings Corp.

GOLF

Acushnet Holdings Corp.

HOLD

Current Price

$86.44

Market Cap

5.1B

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$101.92

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOLF
RYTM
Founded
1910
2008
Country
United States
United States
Employees
7300
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.8B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
GOLF
RYTM
Price
$86.44
$101.92
Analyst Decision
Hold
Strong Buy
Analyst Count
7
14
Target Price
$83.67
$131.14
AVG Volume (30 Days)
410.5K
481.5K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.07%
N/A
EPS Growth
N/A
28.34
EPS
3.44
N/A
Revenue
$1,633,721,000.00
N/A
Revenue This Year
$5.76
$55.34
Revenue Next Year
$2.44
$86.06
P/E Ratio
$25.14
N/A
Revenue Growth
4.71
N/A
52 Week Low
$73.09
$74.50
52 Week High
$119.65
$122.20

Technical Indicators

Market Signals
Indicator
GOLF
RYTM
Relative Strength Index (RSI) 33.34 41.15
Support Level $83.75 $99.14
Resistance Level $92.26 $111.56
Average True Range (ATR) 2.20 4.11
MACD 0.37 -1.27
Stochastic Oscillator 24.82 6.89

Price Performance

Historical Comparison
GOLF
RYTM

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: